We conducted post hoc ( secondary ) analyses of unpublished data from a previously published randomized clinical trial ( NCT00477490 ) of desmopressin ( a medication used to treat nocturia ) and examined relationships between baseline and 4-week change in FUSP and PSQI global and subscale scores for participants ( N = 580 to N = 606 ) having complete data .